VC-backed Checkmate Pharmaceuticals goes public
Cambridge, Massachusetts-based Checkmate Pharmaceuticals, a clinical stage biotechnology company, has raised $75 million for its IPO after pricing its 5 million shares at $15 per share.
Cambridge, Massachusetts-based Checkmate Pharmaceuticals, a clinical stage biotechnology company, has raised $75 million for its IPO after pricing its 5 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination